53 related articles for article (PubMed ID: 8411765)
1. [A study on plasma allantoin in patients undergoing maintenance hemodialysis].
Motomiya Y; Sasaki K; Okajima E; Uji Y; Okabe H
Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):853-8. PubMed ID: 8411765
[TBL] [Abstract][Full Text] [Related]
2. [Plasma allantoin in patients undergoing maintenance hemodialysis].
Sasaki K; Motomiya Y; Oyama N; Hirao Y; Okajima E; Uji Y; Okabe H
Nihon Jinzo Gakkai Shi; 1996 Apr; 38(4):164-70. PubMed ID: 8709415
[TBL] [Abstract][Full Text] [Related]
3. [A new role of uric acid as an antioxidant in human plasma].
Hasegawa T; Kuroda M
Rinsho Byori; 1989 Sep; 37(9):1020-7. PubMed ID: 2607655
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE.
Caussé E; Pradelles A; Dirat B; Negre-Salvayre A; Salvayre R; Couderc F
Electrophoresis; 2007 Feb; 28(3):381-7. PubMed ID: 17177243
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography.
Kand'ár R; Záková P; Muzáková V
Clin Chim Acta; 2006 Mar; 365(1-2):249-56. PubMed ID: 16194528
[TBL] [Abstract][Full Text] [Related]
6. High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction.
Kario K; Matsuo T; Kobayashi H; Matsuo M; Asada R; Koide M
Thromb Haemost; 1995 Oct; 74(4):1020-4. PubMed ID: 8560404
[TBL] [Abstract][Full Text] [Related]
7. Aminothiols and allantoin in chronic dialysis patients: effects of hemodialysis sessions.
Caussé E; Ribes D; Longlune N; Kamar N; Durand D; Salvayre R; Rostaing L
Clin Nephrol; 2010 Jan; 73(1):51-7. PubMed ID: 20040352
[TBL] [Abstract][Full Text] [Related]
8. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of serum sialic acid concentration in chronic renal failure children on continuous ambulatory peritoneal dialysis and hemodialysis].
Szprynger K; Szczepańska M; Mazur B; Dyduch A; Zwolińska D; Morawiec-Knysak A; Makulska I
Pol Merkur Lekarski; 2000 Jul; 8(49):459-61. PubMed ID: 11070713
[TBL] [Abstract][Full Text] [Related]
10. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
11. Global assessment of serum antioxidant status in hemodialysis patients.
Mircescu G; Capuşă C; Stoian I; Vârgolici B; Barbulescu C; Ursea N
J Nephrol; 2005; 18(5):599-605. PubMed ID: 16299688
[TBL] [Abstract][Full Text] [Related]
12. Purine catabolism in advanced carotid artery plaque.
Felici C; Ciari I; Terzuoli L; Porcelli B; Setacci C; Giubbolini M; Marinello E
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1291-4. PubMed ID: 17065109
[TBL] [Abstract][Full Text] [Related]
13. Oxidation of uric acid in rheumatoid arthritis: is allantoin a marker of oxidative stress?
Yardim-Akaydin S; Sepici A; Ozkan Y; Torun M; Simşek B; Sepici V
Free Radic Res; 2004 Jun; 38(6):623-8. PubMed ID: 15346653
[TBL] [Abstract][Full Text] [Related]
14. [Serum sialic acid levels in patients with acute prostatitis or acute epididymitis].
Ohkawa M; Okasho A; Fuse H; Orito M; Sugata T; Hisazumi H
Hinyokika Kiyo; 1985 Dec; 31(12):2161-8. PubMed ID: 3832918
[TBL] [Abstract][Full Text] [Related]
15. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
16. Allantoin as a marker of oxidative stress in human erythrocytes.
Kand'ár R; Záková P
Clin Chem Lab Med; 2008; 46(9):1270-4. PubMed ID: 18636793
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of uric acid in gastric mucosal damage in hemodialysis patients.
Tsukada K; Hasegawa T; Miyazaki T; Katoh H; Yoshikawa M; Masuda N; Ojima H; Tajima K; Fukai Y; Nakajima M; Kamiyama Y; Kuwano H; Yamamoto Y; Tsukada O
Hepatogastroenterology; 2003; 50(53):1708-11. PubMed ID: 14571823
[TBL] [Abstract][Full Text] [Related]
18. Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation.
Santos CX; Anjos EI; Augusto O
Arch Biochem Biophys; 1999 Dec; 372(2):285-94. PubMed ID: 10600166
[TBL] [Abstract][Full Text] [Related]
19. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
Fischer F; Egg G
HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
[TBL] [Abstract][Full Text] [Related]
20. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
